You just read:

Sophiris Bio Presents Topsalysin Data from Phase 2a Proof-of-Concept Study in Localized Prostate Cancer at 112th American Urological Association (AUA) Meeting

News provided by

Sophiris Bio Inc.

May 15, 2017, 07:00 ET